This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Wataru Hirose: Innovator in Anticancer Research
Introduction
Wataru Hirose is a notable inventor based in Suita, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential therapeutic applications.
Latest Patents
Hirose holds a patent for an optically active bridged piperidine derivative. This invention relates to a compound that has shown an anticancer effect by inhibiting the binding between a MLL fusion protein and menin. The compound is characterized by a specific formula, where certain variables can represent hydrogen atoms or other groups, and it may also exist as a pharmaceutically acceptable salt.
Career Highlights
Wataru Hirose is associated with Sumitomo Pharma Co., Ltd., a company known for its commitment to advancing healthcare through innovative pharmaceutical solutions. His work focuses on developing new treatments that target specific cancer pathways, showcasing his dedication to improving patient outcomes.
Conclusion
Wataru Hirose's contributions to anticancer research through his patented inventions highlight the importance of innovation in the pharmaceutical industry. His work continues to pave the way for new therapeutic options in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile